89 results
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
14 Mar 24
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
9:16am
with a Specials License under the UK Medicines and Healthcare products Regulatory Agency (MHRA) regulations. Manufacturing at our site under the Specials … ; contamination or shortage of raw materials or other manufacturing issues; changes in healthcare laws; risks associated with our international
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
13 Feb 24
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
8:10am
manufacturing issues; changes in healthcare laws; risks associated with our international operations; significant competition in the pharmaceutical
8-K
1xtxdk s3ym7l9qe9dnk
21 Dec 23
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
7:10am
8-K
EX-99.1
n9f11xe46rdx
21 Dec 23
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
7:10am
8-K
EX-99.1
1c7xw1gh vxc
14 Nov 23
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
12:00am
8-K
EX-99.1
eiler9 7z
30 Oct 23
Company Pursuing Multiple Additional Strategic Opportunities
7:37am
8-K
EX-99.1
m3nn q76mhi7g
10 Aug 23
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
8:13am
8-K
EX-99.1
c0jp9vm
11 May 23
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
8:12am
8-K
EX-99.1
at3i5md3xkcl1n
10 Nov 22
Entry into a Material Definitive Agreement
8:07am